Week 9 (not Glomerular Injury) Flashcards

(34 cards)

1
Q

Risk factors for prostate cancer

A

Increasing age
First degree relative diagnosed before age of 60
Afro-Caribbean > Caucasian > Asian

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why is there no screening for prostate cancer

A
Over diagnosis 
Over treatment 
Not cost effective 
Poorer quality of life 
May have benign enlargement of prostate
PSA may be raised in inflammation/infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Presentation of prostate cancer

A

Usual - asymptomatic (majority), voiding problems, overactive bladder, bone pain
Unusual - haematuria (advanced)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is prostate cancer diagnosed

A

DRE and serum PSA used to assess whether a biopsy is needed

Transrectal ultrasound guided biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How are lower urinary tract symptoms with prostate cancer treated

A

Transurethral resection of the prostate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What factors influence treatment of prostate cancer

A
Age
Bone scan - sclerotic in bone 
DRE - T1/2 (nodules), T3 (very rough), T4 (rock hard)
Biopsy - Gleason grade 
PSA level
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Treatment for localised established prostate cancer

A

Surveillance
Radical prostatectomy
Low dose brachytherapy (implanted beads)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Treatment for localised developmental prostate cancer

A
High dose brachytherapy
High intensity focused ultrasound 
Primary cryotherapy (freeze prostate)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment for locally advanced prostate cancer

A

Surveillance

Hormones (+/- radiotherapy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Treatment for metastatic prostate cancer

A

Luteinising hormone releasing hormone agonist (eventually lowers LH so lowers testosterone)
Palliative - single dose radiotherapy, bisphosphonates, chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Types of haematuria

A

Visible

Non-visible - symptomatic or asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is non visible haematuria detected

A

Microscopy

Urine dipstick

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Differential diagnosis for haematuria

A
Cancer (RCC, upper tract TCC, bladder, advanced prostate)
Glomerular injury
Stones
Infection
Inflammation
BPH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Important features of history in haematuria

A
Occupation
Smoking
Family history
Pain
Other lower urinary tract symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Things to look for in examination with haematuria

A
BP
Abdominal mass
Varicocele - collection of veins in scrotum 
Leg swelling
DRE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Investigations for haematuria

A

Flexible cystoscopy
Blood - FBC and Us and Es
Urine culture
Ultrasound - hydronephrosis and kidney tumour

17
Q

Demographics of bladder cancer

A

2.5 times more likely in males

Usually more advanced in women

18
Q

What is the most common bladder cancer

A

Transitional cell carcinoma

19
Q

Risk factors for bladder TCC

A

Smoking
Occupational exposure to arylamines and polyaromatic hydrocarbons
Schistosomiasis

20
Q

Incidence of different bladder cancer stages

A

75% superficial - T1 or Ta
5% in situ - Tis
20% muscle invasive - T2-4

21
Q

Bladder cancer stages

A
Tis - just in epithelium, not lumen
Ta - epithelium and lumen 
T1 - subethelial connective tissue (lamina propria)
T2 - into detrusor muscle
T3/4 - into perivesical fat
22
Q

Initial treatment for bladder cancer

A

Transurethral resection of the bladder cancer

23
Q

Treatment for low risk non muscle invasive bladder TCC

A

Check cystoscopies

Intravesical chemotherapy

24
Q

Treatment for high risk non muscle invasive bladder TCC

A

Check cystoscopies

Intravesical immunotherapy

25
Treatment for muscle invasive bladder TCC
If curative - radical cystectomy, radiotherapy, chemotherapy Palliative - chemotherapy or radiotherapy
26
Types and incidence of upper urinary tract tumours
Renal cell carcinoma - 95% Upper tract transitional cell carcinoma - 5%
27
Risk factors of upper urinary tract cancers
RCC - smoking, obesity and dialysis | TCC - smoking, phenacetin abuse and Balkans nephropathy
28
Demographics of renal cell carcinoma
Affects men 1.5 times more than women
29
Where can RCC spread to
Subcapsular fat by perinephric spread Right atrium via renal vein and IVC Lymph nodes Lungs - cannonball metastasis
30
Treatment for localised established RCC
Surveillance Radical nephrectomy - remove kidney, adrenal gland, surrounding fat, upper ureter Partial nephrectomy
31
Treatment for localised developmental RCC
Ablation - removal of tumour from surface via erosion
32
Treatment for metastatic RCC
Palliative - molecular therapies targeting angiogenesis, immunotherapy
33
Investigations for upper tract TCC
Ultrasound - hydronephrosis CT urogram - filling defect or Ureteric stricture Retrograde pyelogram (inject contrast into ureter) Ureteroscopy - biopsy
34
Treatment for upper tract TCC
Nephrourectomy - remove kidney, surrounding fat, ureter and bladder cuff